National & Kapodistrian University of Athens, Athens (Greece)
5
presentations
3
followers
7
more
presentations
in this session
Dulaglutide is cardioprotective with or without background metformin in patients with diabetes and established or high risk for coronary vascular disease. A subgroup analysis of the REWIND Trial.